Click to view in your browser (mobile-friendly version)

THE MEANING OF MYRIAD

Patent Law Conference

Friday, September 12, 2014
9:00 a.m.–5:00 p.m.
UC Irvine School of Law (map)

In 2013, the United States Supreme Court rendered its decision on gene patenting in Association of Molecular Pathology v. Myriad Genetics. The reasoning of the Myriad decision itself remains anything but clear. This conference will explore the evolving meaning of the Myriad decision for science, for industry, and for the patent system.

Keynote Speaker

Hon. Andrew Guilford, USDC Cent. Dist. Cal

Confirmed Speakers

Dan Burk, University of California, Irvine
Mark Janis, University of Indiana, Bloomington
Anna Laakman, Lewis & Clark University
Jessica Lai, University of Lucerne
Peter Lee, University of California, Davis
Mark Lemley, Stanford University
Lisa Larrimore Ouellette, Stanford University
Amelia Rinehart, University of Utah
Brad Sherman, Griffith University

Register online now >

CLE credit available

Full conference details available at
law.uci.edu/events/ip-law/meaning-of-myriad-2014/

More about
Intellectual Property programs at UC Irvine School of Law

Questions about the conference?
Email events@law.uci.edu